The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is ...
The drug shortages are the result of manufacturing problems, increased demand, and other issues. View on euronews ...
4d
GlobalData on MSNUnsafe and unregulated cell therapies being sold in EuropeThe EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...
Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...
At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...
From funding challenges to what changes in joint drug procurement: Here’s what you need to know about the new rules aimed at ...
Robert F. Kennedy Jr. addressed the worsening avian flu crisis, saying vaccinating birds turns them into “mutation factories.
Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start a Phase 2 trial for PRX-115 in 2025.
Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...
Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved Rxulti (brexpiprazole) for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results